SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

ChromaDex Corp. – ‘10-Q’ for 3/31/21 – ‘R44’

On:  Thursday, 5/6/21, at 4:01pm ET   ·   For:  3/31/21   ·   Accession #:  1654954-21-5211   ·   File #:  1-37752

Previous ‘10-Q’:  ‘10-Q’ on 11/4/20 for 9/30/20   ·   Next:  ‘10-Q’ on 8/3/21 for 6/30/21   ·   Latest:  ‘10-Q’ on 5/8/24 for 3/31/24   ·   15 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 5/06/21  ChromaDex Corp.                   10-Q        3/31/21   63:4.6M                                   Blueprint/FA

Quarterly Report   —   Form 10-Q

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    730K 
 2: EX-10.2     Executive Employment Agreement, Dated November 13,  HTML    109K 
                2020                                                             
 3: EX-10.3     Consultant Agreement                                HTML     53K 
 4: EX-10.4     Consent to Business Financing Agreement             HTML     35K 
 5: EX-31.1     Certification of the Chief Executive Officer        HTML     21K 
 6: EX-31.2     Certification of the Chief Financial Officer        HTML     21K 
 7: EX-32.1     Certification Pursuant to 18 U.S.C. Section 1350    HTML     18K 
14: R1          Cover                                               HTML     71K 
15: R2          Condensed Consolidated Balance Sheets               HTML     82K 
16: R3          Condensed Consolidated Balance Sheets               HTML     33K 
                (Parenthetical)                                                  
17: R4          Condensed Consolidated Statements of Operations     HTML     51K 
18: R5          Condensed Consolidated Statement of Stockholders'   HTML     43K 
                Equity                                                           
19: R6          Condensed Consolidated Statements of Cash Flows     HTML     91K 
20: R7          Interim Financial Statements                        HTML     20K 
21: R8          Nature of Business                                  HTML     20K 
22: R9          Liquidity                                           HTML     21K 
23: R10         Significant Accounting Policies                     HTML     21K 
24: R11         Earnings Per Share Applicable to Common             HTML     32K 
                Stockholders                                                     
25: R12         Related Party Transactions                          HTML     22K 
26: R13         Inventories                                         HTML     25K 
27: R14         Stock Issuance                                      HTML     19K 
28: R15         Leases                                              HTML     36K 
29: R16         ShareBased Compensation                             HTML     97K 
30: R17         Business Segments                                   HTML    167K 
31: R18         Commitments and Contingencies                       HTML     51K 
32: R19         Significant Accounting Policies (Policies)          HTML     23K 
33: R20         Earnings Per Share Applicable to Common             HTML     31K 
                Stockholders (Tables)                                            
34: R21         Related Party Transactions (Tables)                 HTML     21K 
35: R22         Inventories (Tables)                                HTML     26K 
36: R23         Leases (Tables)                                     HTML     38K 
37: R24         ShareBased Compensation (Tables)                    HTML     99K 
38: R25         Business Segments (Tables)                          HTML    169K 
39: R26         Liquidity (Details Narrative)                       HTML     35K 
40: R27         Earnings Per Share Applicable to Common             HTML     30K 
                Stockholders (Details)                                           
41: R28         Earnings Per Share Applicable to Common             HTML     18K 
                Stockholders (Details Narrative)                                 
42: R29         Related Party Transactions (Details)                HTML     22K 
43: R30         Inventories (Details)                               HTML     27K 
44: R31         Stock Issuance (Details Narrative)                  HTML     24K 
45: R32         Leases (Details)                                    HTML     27K 
46: R33         Leases (Details 1)                                  HTML     21K 
47: R34         Leases (Details 2)                                  HTML     40K 
48: R35         Leases (Details Narrative)                          HTML     19K 
49: R36         ShareBased Compensation (Details)                   HTML     26K 
50: R37         ShareBased Compensation (Details 1)                 HTML     62K 
51: R38         ShareBased Compensation (Details 2)                 HTML     54K 
52: R39         ShareBased Compensation (Details 3)                 HTML     37K 
53: R40         ShareBased Compensation (Details 4)                 HTML     24K 
54: R41         ShareBased Compensation (Details Narrative)         HTML     26K 
55: R42         Business Segments (Details)                         HTML     52K 
56: R43         Business Segments (Details 1)                       HTML     25K 
57: R44         Business Segments (Details 22)                      HTML     50K 
58: R45         Business Segments (Details 3)                       HTML     29K 
59: R46         Commitments and Contingencies (Details Narrative)   HTML     30K 
61: XML         IDEA XML File -- Filing Summary                      XML    104K 
13: XML         XBRL Instance -- cdxc_10q_htm                        XML   1.16M 
60: EXCEL       IDEA Workbook of Financial Reports                  XLSX     61K 
 9: EX-101.CAL  XBRL Calculations -- cdcx-20210331_cal               XML    120K 
10: EX-101.DEF  XBRL Definitions -- cdcx-20210331_def                XML    275K 
11: EX-101.LAB  XBRL Labels -- cdcx-20210331_lab                     XML    593K 
12: EX-101.PRE  XBRL Presentations -- cdcx-20210331_pre              XML    506K 
 8: EX-101.SCH  XBRL Schema -- cdcx-20210331                         XSD    120K 
62: JSON        XBRL Instance as JSON Data -- MetaLinks              204±   274K 
63: ZIP         XBRL Zipped Folder -- 0001654954-21-005211-xbrl      Zip    175K 


‘R44’   —   Business Segments (Details 22)


This is an IDEA Financial Report.  [ Alternative Formats ]



 
v3.21.1
Business Segments (Details 22) - USD ($)
$ in Thousands
3 Months Ended
Net sales $ 14,683 $ 14,345
TRU NIAGEN Consumer Product    
Net sales 12,437 11,144
NIAGEN Ingredient    
Net sales 1,203 1,961
NIAGEN Related    
Net sales 13,640 13,105
Other Ingredients    
Net sales 112 514
Reference Standards    
Net sales 800 673
Consulting and Other    
Net sales 131 53
Other Goods and Services    
Net sales 1,043 1,240
Consumer Products Segment [Member]    
Net sales 12,437 11,144
Consumer Products Segment [Member] | TRU NIAGEN Consumer Product    
Net sales 12,437 11,144
Consumer Products Segment [Member] | NIAGEN Ingredient    
Net sales 0 0
Consumer Products Segment [Member] | NIAGEN Related    
Net sales 12,437 11,144
Consumer Products Segment [Member] | Other Ingredients    
Net sales 0 0
Consumer Products Segment [Member] | Reference Standards    
Net sales 0 0
Consumer Products Segment [Member] | Consulting and Other    
Net sales 0 0
Consumer Products Segment [Member] | Other Goods and Services    
Net sales 0 0
Ingredients Segment [Member]    
Net sales 1,315 2,475
Ingredients Segment [Member] | TRU NIAGEN Consumer Product    
Net sales 0 0
Ingredients Segment [Member] | NIAGEN Ingredient    
Net sales 1,203 1,961
Ingredients Segment [Member] | NIAGEN Related    
Net sales 1,203 1,961
Ingredients Segment [Member] | Other Ingredients    
Net sales 112 514
Ingredients Segment [Member] | Reference Standards    
Net sales 0 0
Ingredients Segment [Member] | Consulting and Other    
Net sales 0 0
Ingredients Segment [Member] | Other Goods and Services    
Net sales 112 514
Analytical Reference Standards and Services Segment [Member]    
Net sales 931 726
Analytical Reference Standards and Services Segment [Member] | TRU NIAGEN Consumer Product    
Net sales 0 0
Analytical Reference Standards and Services Segment [Member] | NIAGEN Ingredient    
Net sales 0 0
Analytical Reference Standards and Services Segment [Member] | NIAGEN Related    
Net sales 0 0
Analytical Reference Standards and Services Segment [Member] | Other Ingredients    
Net sales 0 0
Analytical Reference Standards and Services Segment [Member] | Reference Standards    
Net sales 800 673
Analytical Reference Standards and Services Segment [Member] | Consulting and Other    
Net sales 131 53
Analytical Reference Standards and Services Segment [Member] | Other Goods and Services    
Net sales $ 931 $ 726

Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-Q’ Filing    Date    Other Filings
Filed on:5/6/218-K
For Period end:3/31/21
3/31/2010-Q,  3,  NT 10-Q
 List all Filings 


3 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/06/24  ChromaDex Corp.                   10-K       12/31/23   95:9.1M                                   Workiva Inc Wde… FA01/FA
 3/08/23  ChromaDex Corp.                   10-K       12/31/22   93:9.2M                                   Workiva Inc Wde… FA01/FA
 3/14/22  ChromaDex Corp.                   10-K       12/31/21   91:9.9M                                   Workiva Inc Wde… FA01/FA


12 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/22/21  ChromaDex Corp.                   8-K:1,9     2/20/21   14:678K                                   Blueprint/FA
 4/29/20  ChromaDex Corp.                   8-K:1,9     4/27/20    3:490K                                   Blueprint/FA
 8/15/19  ChromaDex Corp.                   8-K:1,3,9   8/15/19    2:213K                                   Blueprint/FA
 5/10/19  ChromaDex Corp.                   8-K:1,9     5/09/19    4:534K                                   Blueprint/FA
 3/07/19  ChromaDex Corp.                   10-K       12/31/18  103:9.2M                                   Blueprint/FA
 3/15/18  ChromaDex Corp.                   10-K       12/30/17  104:9.3M                                   Blueprint/FA
11/09/17  ChromaDex Corp.                   10-Q        9/30/17   61:5.2M                                   Blueprint/FA
 7/19/16  ChromaDex Corp.                   8-K:5,9     7/14/16    2:29K                                    SEC Connect
 4/12/16  ChromaDex Corp.                   8-K:5,8,9   4/12/16    3:286K                                   SEC Connect
 3/17/16  ChromaDex Corp.                   10-K        1/02/16   99:9.3M                                   SEC Connect
 4/03/09  ChromaDex Corp.                   10-K        1/03/09    7:927K                                   Donnelley … Solutions/FA
 6/24/08  ChromaDex Corp.                   8-K:1,2,3,4 6/20/08   23:2.8M                                   Bowne - BPC/FA
Top
Filing Submission 0001654954-21-005211   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Fri., May 10, 8:17:07.2am ET